本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Reneo Pharmaceuticals, Inc.

18.20
0.0000
成交量:- -
成交额:79.46万
市值:6,084.04万
市盈率:-10.81
高:18.20
开:18.20
低:18.20
收:18.20
数据加载中...
2024/08/13

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/07/27

SEC问询函

Form CORRESP - Correspondence
2024/05/21

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/13

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/05/13

重要事件披露

Form 8-K - Current report
2024/05/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/26

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/26

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/12/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/14

重要事件披露

Form 8-K - Current report
2023/11/18

SEC问询函

Form CORRESP - Correspondence
2023/11/13

重要事件披露

Form 8-K - Current report